Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS101 topical treatment for external genital warts
ACTRN12607000580471Phase 2Not yet recruiting
- Sponsor
- Miramar Therapeutics
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of AS-101 in anogenital warts, sponsored by Miramar Therapeutics. Planned start Jan 2008; status: not yet recruiting.
02
Drugs
AS-101
03
Conditions
anogenital warts
Beyond the preview
Go deeper on ACTRN12607000580471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000580471.